Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/23/06 | UPLOAD | SEC-generated letter |
|
2 | |
| 10/20/06 | 8-K | Current report filing |
|
2 | |
| 10/16/06 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 10/10/06 | UPLOAD | SEC-generated letter |
|
2 | |
| 10/06/06 | 8-K | Current report filing |
|
4 | |
| 10/03/06 | 8-K/A | Current report filing |
|
26 | |
| 09/26/06 | 8-K/A | Current report filing |
|
3 | |
| 09/07/06 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 09/06/06 | UPLOAD | SEC-generated letter |
|
2 | |
| 09/05/06 | 8-K/A | Current report filing |
|
3 |
